Literature DB >> 3531913

'Fingerprints' of central stimulatory drug effects by means of quantitative radioelectroencephalography in the rat (tele-stereo-EEG).

W Dimpfel, M Spüler, B Nickel, U Tibes.   

Abstract

The new electrophysiological model earlier described as stereo-EEG is extended now to allow recording from the freely moving rat by means of a telemetric device. Chronic implantation of 4 electrodes into the brain allows simultaneous transmission of field potentials from frontal cortex, hippocampus, striatum and reticular formation. Frequency analysis of these potentials results in a drug-specific 'fingerprint' which cannot only be used to compare different chemicals with each other but also to detect onset and time dependence of drug actions. Application of the model to the question if fenetylline has its own intrinsic mode of action or merely develops its stimulatory effect after metabolic separation into its molecular moieties amphetamine and theophylline (prodrug hypothesis) revealed that fenetylline indeed displays its own stimulatory effect to the same extent and at a similar time course as amphetamine and theophylline. The 'fingerprint' as obtained by the analysis of the action of fenetylline in the rat resembles closely that obtained after the application of theophylline with respect to decreased alpha activity, but resembles amphetamine with respect to beta 1 activity. Thus the applied method allows studying structure function relationships as the action of fenetylline seems to reflect both its molecular moieties.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3531913     DOI: 10.1159/000118250

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  9 in total

1.  Conditioning of apomorphine effects: simultaneous analysis of the alterations in cortical electroencephalogram and behaviour.

Authors:  W Kropf; K Kuschinsky; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

2.  Effects of cocaine on the EEG power spectrum of rats are significantly altered after its repeated administration: do they reflect sensitization phenomena?

Authors:  B Ferger; D Stahl; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

3.  Effects of morphine on EEG in rats and their possible relations to hypo- and hyperkinesia.

Authors:  B Ferger; K Kuschinsky
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

4.  Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors.

Authors:  B Ferger; W Kropf; K Kuschinsky
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

5.  Conditioned effects of apomorphine are manifest in regional EEG of rats both in hippocampus and in striatum.

Authors:  W Kropf; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

6.  Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).

Authors:  W Dimpfel; M Spüler; D E Nichols
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Activation of dopamine D1 receptors or alpha 1 adrenoceptors is not involved in the EEG effect of nicotine in rats.

Authors:  B Ferger; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

8.  Apomorphine-induced alterations in cortical EEG activity of rats. Involvement of D-1 and D-2 dopamine receptors.

Authors:  W Kropf; K Kuschinsky; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

9.  Vaccine-driven pharmacodynamic dissection and mitigation of fenethylline psychoactivity.

Authors:  Cody J Wenthur; Bin Zhou; Kim D Janda
Journal:  Nature       Date:  2017-08-16       Impact factor: 49.962

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.